Press Release Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Aug 17
Press Release Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates Aug 6
Press Release Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 3